Cloning of a D-type cyclin from murine erythroleukemia cells

  1. H Kiyokawa,
  2. X Busquets,
  3. C T Powell,
  4. L Ngo,
  5. R A Rifkind, and
  6. P A Marks
  1. DeWitt Wallace Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY.

Abstract

We report the complete coding sequence of a cDNA, designated CYL2, derived from a murine erythroleukemia cell library. CYL2 is considered to encode a D-type cyclin because (i) there is cross hybridization with CYL1 (a murine homolog of human cyclin D1) and the encoded protein has 64% amino acid sequence identity with CYL1 and (ii) murine erythroleukemia cell-derived CYL2 contains an amino acid sequence identical to that previously reported for the C-terminal portion of a partially sequenced CYL2. Transcripts of murine erythroleukemia cell CYL2 undergo alternative polyadenylylation like that of human cyclin D1. A major 6.5-kilobase CYL2 transcript changes its expression during the cell cycle with a broad peak through G1 and S phases and a decrease in G2/M phases. The present findings suggest that CYL2 plays a role in the G1 to S phase progression.

« Previous | Next Article »Table of Contents